Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression. | Cancers (Basel) | 2023 | 38001623 | PubTator, text mining | PubMed |
| The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases. | Diagnostics (Basel) | 2023 | 37998534 | PubTator, text mining | PubMed |
| Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. | Dis Model Mech | 2023 | 37990867 | PubTator, text mining | PubMed |
| scCURE identifies cell types responding to immunotherapy and enables outcome prediction. | Cell Rep Methods | 2023 | 37989083 | PubTator, text mining | PubMed |
| Treponema pallidum Promotes the Polarization of M2 Subtype Macrophages to M1 Subtype Mediating the Apoptosis and Inhibiting the Angiogenesis of Human Umbilical Vein Endothelial Cells. | ACS Infect Dis | 2023 | 37983134 | PubTator, text mining | PubMed |
| Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study. | JMIR Res Protoc | 2023 | 37976081 | PubTator, text mining | PubMed |
| Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer. | Explor Target Antitumor Ther | 2023 | 37970212 | PubTator, text mining | PubMed |
| Tumour-associated macrophages: versatile players in the tumour microenvironment. | Front Cell Dev Biol | 2023 | 37965573 | PubTator, text mining | PubMed |
| The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank. | Front Immunol | 2023 | 37965317 | PubTator, text mining | PubMed |
| EG-VEGF maternal levels predict spontaneous preterm birth in the second and third trimesters in pregnant women with risk factors for placenta-mediated complications. | Sci Rep | 2023 | 37963927 | PubTator, text mining | PubMed |
| The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK. | Int J Mol Sci | 2023 | 37958886 | PubTator, text mining | PubMed |
| Cholinergic Polarization of Human Macrophages. | Int J Mol Sci | 2023 | 37958716 | PubTator, text mining | PubMed |
| The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment. | Cancers (Basel) | 2023 | 37958467 | PubTator, text mining | PubMed |
| The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma. | Cancers (Basel) | 2023 | 37958292 | PubTator, text mining | PubMed |
| Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity. | Exp Clin Endocrinol Diabetes | 2023 | 37956971 | PubTator, text mining | PubMed |
| CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation. | J Transl Med | 2023 | 37950246 | PubTator, text mining | PubMed |
| IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages. | Sci Rep | 2023 | 37949903 | PubTator, text mining | PubMed |
| CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers. | Aging (Albany NY) | 2023 | 37944262 | PubTator, text mining | PubMed |
| Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies. | Front Immunol | 2023 | 37942334 | PubTator, text mining | PubMed |
Genomic analysis of penicillin-binding proteins and recombination events in an emerging amoxicillin- and meropenem-resistant PMEN3 (Spain9V-3, ST156) variant in Taiwan and comparison with global descendants of this lineage. | Microbiol Spectr | 2023 | 37930013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=20